Arlington, MA, United States of America

Ramkumar Iyer

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Entasis Therapeutics, Inc.. Active years: 2025.


% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Ramkumar Iyer

Introduction

Ramkumar Iyer is an accomplished inventor based in Arlington, MA (US). He has made significant contributions to the field of microbial dysbiosis management through his innovative research and patent work. His expertise lies in developing methods to control microbial imbalances, particularly those caused by enterobacteriaceae overgrowth.

Latest Patents

Ramkumar Iyer holds a patent titled "Managing microbial dysbiosis with temocillin." This patent outlines methods for using temocillin to address microbial dysbiosis, specifically targeting conditions arising from adherent invasive E. coli (AIEC) overgrowth. The patent also discusses the potential of temocillin in treating intestinal disorders and alleviating symptoms associated with microbial dysbiosis.

Career Highlights

Currently, Ramkumar Iyer is associated with Entasis Therapeutics, Inc., where he continues to advance his research in microbial management. His work is pivotal in developing therapeutic strategies that can improve patient outcomes in gastrointestinal health.

Collaborations

Throughout his career, Ramkumar has collaborated with notable colleagues, including Adam Shapiro and Samir Moussa. These collaborations have fostered a dynamic research environment, enhancing the development of innovative solutions in the field.

Conclusion

Ramkumar Iyer's contributions to the management of microbial dysbiosis through his patent and work at Entasis Therapeutics, Inc. highlight his role as a key innovator in the field. His research continues to pave the way for advancements in treating intestinal disorders.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…